Evidence map›Paper›PMID 30534252›Full record

ArticleJournal of cardiology cases2014

Two-week administration of rivaroxaban resolved left atrial thrombus.

Toru Kato, Masahiro Yasaka, Taku Yabuki, Taichi Adachi, Shigeru Toyoda, Teruo Inoue

Open access · bronzeAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cardiology cases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Toru KatoDepartment of Clinical Research, National Hospital Organization Tochigi Medical Center, Tochigi, Japan.
Masahiro YasakaDepartment of Cerebrovascular Medicine, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
Taku YabukiDepartment of Internal Medicine, National Hospital Organization Tochigi Medical Center, Tochigi, Japan.
Taichi AdachiDepartment of Cardiovascular Medicine, National Hospital Organization Tochigi Medical Center, Tochigi, Japan.
Shigeru ToyodaDepartment of Cardiovascular Disease, Dokkyo Medical University, Tochigi, Japan.
Teruo InoueDepartment of Cardiovascular Disease, Dokkyo Medical University, Tochigi, Japan.
National Hospital Organization · JPDokkyo Medical University · JPNational Kyushu Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An 89-year-old man visited our hospital complaining of palpitation. Electrocardiography showed atrial fibrillation, and transthoracic echocardiography demonstrated a mobile thrombus of 28.6 mm × 20.8 mm in the left atrium. Administration of a direct factor Xa inhibitor rivaroxaban (10 mg/day) was started. The thrombus reduced its size and disappeared completely 2 weeks after the commencement of rivaroxaban treatment. To our knowledge, this is the first case report that rivaroxaban successfully dissolved left atrial thrombus during a short period. Rivaroxaban might have a potential, not only to prevent de novo thrombus formation, but also to dissolve established thrombi by direct inhibition of free and thrombus-associated factor Xa. <

Indexed as

AnticoagulationAtrial fibrillationIntracardiac thrombusNonvalvular atrial fibrillationRivaroxaban

Identifiers

PMID30534252
PMCPMC6279631
OpenAlexW2090496787

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.